This white paper from NSF consultant Richard Kettlewell builds on an earlier white paper from Pete Gough, which introduced the regulatory expectations for Stage 3 of the process verification lifecycle.

This article poses questions to pharmaceutical manufacturers as to how and why the concepts of Stage 3 could be built into pharmaceutical quality systems.

Download to find out more.

This white paper from NSF consultant Richard Kettlewell builds on an earlier white paper from Pete Gough, which introduced the regulatory expectations for Stage 3 of the process verification lifecycle.

This article poses questions to pharmaceutical manufacturers as to how and why the concepts of Stage 3 could be built into pharmaceutical quality systems.

Download to find out more.